Abnormal Uterine Bleeding

Women's Health
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

H
HologicMA - Marlborough
1 program
Interlace Medical 1st Generation Hysteroscopic MorcellatorN/A1 trial
Active Trials
NCT01026805Completed11Est. Mar 2009

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HologicInterlace Medical 1st Generation Hysteroscopic Morcellator

Clinical Trials (1)

Total enrollment: 11 patients across 1 trials

NCT01026805HologicInterlace Medical 1st Generation Hysteroscopic Morcellator

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

Start: Feb 2009Est. completion: Mar 200911 patients
N/ACompleted

Related Jobs in Women's Health

Senior Medical Science Liaison

Ferring Pharmaceuticals
Bangkok, Thailand
2d ago

Senior Key Account Manager

Ferring Pharmaceuticals
Bucureşti, Romania
1w ago

Territory Representative - Miami

Caldera Medical
Miami, FL, US
1w ago

Sales Representative Gynecological Health

Medtronic
Malaga, Andalucia, Spain
1w ago

Senior Client Solutions Manager

Progyny
New York, New York
1w ago
$85K - $95K/yr

Medical Science Liaison

Ferring Pharmaceuticals
São Paulo, Brazil
1w ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Endometriosis(46)Menopause(27)Polycystic Ovary Syndrome(14)Uterine Fibroids(8)Postmenopause(8)Controlled Ovarian Stimulation(5)Preeclampsia(4)Vasomotor Symptoms Associated With Menopause(4)Ovarian Hyperstimulation Syndrome(3)Polycystic Ovarian Syndrome(3)